Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000185848 | SCV000238799 | likely pathogenic | not provided | 2014-01-18 | criteria provided, single submitter | clinical testing | p.Ala61Val (GCC>GTC): c.182 C>T in exon 3 of the DLD gene (NM_000108.3) An A61V missense change that is likely pathogenic was identified in the DLD gene. It has not been published as a mutation, nor has it been reported as a benign polymorphism to our knowledge. The A61V variant is a conservative amino acid substitution as these residues share similar properties, and are less likely to impact secondary structure. However, this substitution occurs at a highly conserved position in the DLD protein, and multiple in-silico analysis programs predict that A61V is damaging to the DLD protein. Therefore, A61V is a strong candidate for a disease-causing mutation, however the possibility that it is a benign variant cannot be excluded. The variant is found in MITONUC-MITOP panel(s). |